Form 144: 18,741 Restricted Stock Units reported

Morgan Stanley Smith Barney LLC submitted a Form 144 disclosing the proposed sale of 18,741 shares of Common stock described as Restricted Stock Units and reporting two recent Rule 10b5-1 sales by Brendan Mulligan.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 disclosing the proposed sale of 18,741 shares of Common stock described as Restricted Stock Units and reporting two recent Rule 10b5-1 sales by Brendan Mulligan.

The filing lists a securities-to-be-sold entry showing 18,741 Restricted Stock Units dated 04/01/2026. It also reports two 10b5-1 dispositions of 4,817 shares on 03/03/2026 and 03/16/2026 with proceeds shown as $136,303.28 and $126,687.10, respectively.

Insights

Securities Compliance Specialist

Form 144 filed for RSU sale and recent Rule 10b5-1 dispositions.

The entry lists 18,741 Restricted Stock Units to be sold with an effective date of 04/01/2026. The filing also records two prior Rule 10b5-1 sales of 4,817 shares each on 03/03/2026 and 03/16/2026.

Court or regulatory conditions are not stated; cash-flow treatment and purchaser details are not included in the excerpt. Subsequent filings or broker confirmations would provide settlement and allocation details.

Equity Markets Analyst

Routine broker notice documenting planned RSU resale and prior plan sales.

The filing records a broker-dealer submission for resale of 18,741 shares described as Restricted Stock Units and documents two 10b5-1 sales with proceeds of $136,303.28 and $126,687.10.

This is a disclosure of transactions rather than operational or financial performance; market impact depends on execution timing and whether the sales occur under an ATS or block trade.

Key Figures

Securities to be sold: 18,741 shares 10b5-1 sale on 03/03/2026: 4,817 shares 10b5-1 sale on 03/16/2026: 4,817 shares +1 more

4 metrics

Securities to be sold 18,741 shares Restricted Stock Units dated 04/01/2026

10b5-1 sale on 03/03/2026 4,817 shares Proceeds reported as $136,303.28

10b5-1 sale on 03/16/2026 4,817 shares Proceeds reported as $126,687.10

Proceeds listed (aggregate lines) $456,530.76 Amount shown in filer summary row (as provided)

Key Terms

Restricted Stock Units, 10b5-1 Sales, Form 144

3 terms

Restricted Stock Units financial

"Securities To Be Sold ... Restricted Stock Units ... 04/01/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for BRENDAN MULLIGAN ... 03/16/2026 ... 03/03/2026"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Form 144 regulatory

"Filer Information ... Securities To Be Sold ... Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for FIG disclose?

It discloses the proposed sale of 18,741 Restricted Stock Units dated 04/01/2026. The filing also reports two Rule 10b5-1 sales of 4,817 shares each on 03/03/2026 and 03/16/2026.

Who executed the recent 10b5-1 sales listed in the filing?

The two Rule 10b5-1 transactions are attributed to Brendan Mulligan. Each sale shows 4,817 shares sold, with proceeds of $136,303.28 and $126,687.10, respectively, on the dates provided.

Are the proceeds from the reported sales shown on the Form 144?

Yes, the excerpt lists proceeds for the two 10b5-1 sales as $136,303.28 (03/03/2026) and $126,687.10 (03/16/2026). The filing does not state how proceeds will be used.

What security type is being offered under this Form 144?

The filing identifies the security as Common stock described as Restricted Stock Units with a listed amount of 18,741 shares and an associated date of 04/01/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 04:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002073801
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FIGMA, INC.
SEC File Number	001-42761
Address of Issuer	760 Market Street, Floor 10 San Francisco CALIFORNIA 94102
Phone	4158905404
Name of Person for Whose Account the Securities are To Be Sold	BRENDAN MULLIGAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18741	456530.76	445682595	05/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2026	Restricted Stock Units	Issuer			18741	04/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRENDAN MULLIGAN 760 Market Street, Floor 10 San Francisco CA 94102	Common	03/16/2026	4817	126687.10
10b5-1 Sales for BRENDAN MULLIGAN 760 Market Street, Floor 10 San Francisco CA 94102	Common	03/03/2026	4817	136303.28

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 04/01/2026 through 05/01/2026.
Date of Notice	05/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/05/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brendan Mulligan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)